| __timestamp | BioCryst Pharmaceuticals, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 13486000 | 55402000 |
| Thursday, January 1, 2015 | 46361000 | 66107000 |
| Friday, January 1, 2016 | 23654000 | 103402000 |
| Sunday, January 1, 2017 | 23484000 | 135736000 |
| Monday, January 1, 2018 | 20182000 | 245116000 |
| Tuesday, January 1, 2019 | 44734000 | 108935000 |
| Wednesday, January 1, 2020 | 16136000 | 156000000 |
| Friday, January 1, 2021 | 149906000 | 214957000 |
| Saturday, January 1, 2022 | 264233000 | 143418000 |
| Sunday, January 1, 2023 | 326751000 | 96265000 |
Unleashing the power of data
In the competitive world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, Ligand Pharmaceuticals Incorporated and BioCryst Pharmaceuticals, Inc. have been vying for dominance in gross profit generation. From 2014 to 2023, Ligand Pharmaceuticals consistently outperformed BioCryst, with a peak gross profit in 2018 that was nearly 12 times higher than BioCryst's lowest point in 2014. However, the tide began to turn in 2021, as BioCryst's gross profit surged by over 100% in just two years, surpassing Ligand by 2023. This remarkable growth highlights BioCryst's strategic advancements and market adaptability. As the biotech landscape evolves, these companies exemplify the dynamic nature of financial success in the industry.
Key Insights on Gross Profit: AbbVie Inc. vs BioCryst Pharmaceuticals, Inc.
Merck & Co., Inc. and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated Trends
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated
Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Viatris Inc. vs Ligand Pharmaceuticals Incorporated
Bio-Techne Corporation and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Ascendis Pharma A/S vs Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs Ligand Pharmaceuticals Incorporated
Gross Profit Analysis: Comparing Perrigo Company plc and BioCryst Pharmaceuticals, Inc.
MorphoSys AG and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? HUTCHMED (China) Limited or Ligand Pharmaceuticals Incorporated